VEGFA and cancer: Two strategies commonly utilized to target VEGF signaling, anti-VEGF antibody, and small-molecule inhibitors of VEGF receptor tyrosine kinase, have been tested extensively in preclinical pediatric cancer models (reviewed in [154]).